Other DealsQuestion: Is there anything in this proposal from Citibank/Eastern that would prevent a pharma (or other interested parties) from making an offer at any time for RVX (including in the period between today and the vote date in August)?
My guess is that this possibility is still open.
In my estimation, the Citibank/Eastern arrangement and the share purchases by officers/directors are a strong sign that pharma sees value here... and that a deal after RE-MACE has a high likelihood.
Might this also mean that a deal before then is also a possibility? Do we have any evidence that might rule that out? I don't think so.
So there still may be the potential for a deal at any time. Perhaps this arrangement is intended (in part) to smoke out any potential offers out there. Any pharma kicking our tires must know now that RVX is in a strong negotiating position.
That strong negotiating position is in both the near-term and the longer term.
IMHO. DYODD.